Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica (Q35640506)
Jump to navigation
Jump to search
scientific article published on 19 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica |
scientific article published on 19 May 2015 |
Statements
1 reference
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica (English)
1 reference
Karel Pacak
1 reference
Electron Kebebew
1 reference
Naris Nilubol
1 reference
Paul Meltzer
1 reference
Seth M Steinberg
1 reference
Vladimir Neychev
1 reference
Candice Cottle-Delisle
1 reference
Roxanne Merkel
1 reference
Stephen Marx
1 reference
Jianhua Yao
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference